Asia Stem Cell Center

Immuno Cell Theraphy

Stem Cell for Immuno Cell Theraphy

Cancer is the name given to a collection of related diseases. In all types of cancer, some of the body’s cells begin to divide without stopping and spread into surrounding tissues. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place.

When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors. Many cancers form solid tumors, which are masses of tissue. Cancer of the blood such as leukemia, do not form solid tumors. Cancerous tumors are malignant, which means they can spread into, or invade nearby tissues. In addition, as this tumor grows, some cancer can break off and travel to distant places in the body through the blood or the lymph system and form new tumors far from the original tumor.

Recently, immunotherapy strategies have been used to target cancer cells. Adaptive T-cells, dendritic cell (DC)-based vaccines, oncolytic viruses, immune checkpoint inhibitors, and combination therapies are now being used to target cancer cells. Our own stem cells (derived from adipose mesenchymal stem cell or peripheral blood stem cells) can target cancer cells through immune cells such as cytokine-induced killer (CIK) cells, NK (natural killer) cells, T-cells, and CD8+ T-cells, and are being used for recent advance in Cancer Immunotherapy.